Multiple duodenal ulcer: natural history and pathophysiology
- PMID: 3119434
- PMCID: PMC1433233
- DOI: 10.1136/gut.28.9.1134
Multiple duodenal ulcer: natural history and pathophysiology
Abstract
It has not been established whether multiple duodenal ulcer is associated with a different natural history, pathophysiology, and therapeutic response than a single duodenal ulcer. A consecutive series of 96 patients with two or more duodenal ulcers at endoscopy, representing 9.6% of the total number of new patients with duodenal ulcer seen during the period 1980-1985, were compared with a random series of 200 patients with single duodenal ulcer seen in the middle years of this period. Multiple duodenal ulcer was associated with higher (p less than 0.02) male to female ratio, more (p less than 0.05) late onset patients (those with ulcer symptoms starting after age 30 years, more (p less than 0.05) chronic cigarette smokers, and more frequent (p less than 0.05) moderate to severe deformity of the duodenal bulb. More (p less than 0.05) patients with multiple duodenal ulcer had abnormally low D50 derived from pentagastrin dose response tests, indicating that they were more sensitive to gastrin stimulation. Furthermore, their mean fasting and meal stimulated serum gastrin concentrations were significantly higher than those of patients with single ulcer (p less than 0.005), or of controls (p less than 0.05). Compared with single duodenal ulcer, multiple ulcer had significantly lower placebo healing rate, and required a higher dose of misoprostol (1200 v 800 micrograms/day) to achieve a similar healing efficacy at four weeks. We conclude that multiple duodenal ulcer is associated with different clinical features, pathophysiology, and possibly therapeutic response from single duodenal ulcer, and appears to represent the more aggressive side of the ulcer spectrum.
Similar articles
-
Prostaglandin E1 (misoprostol) overcomes the adverse effect of chronic cigarette smoking on duodenal ulcer healing.Dig Dis Sci. 1986 Feb;31(2 Suppl):68S-74S. doi: 10.1007/BF01309326. Dig Dis Sci. 1986. PMID: 3080292 Clinical Trial.
-
Misoprostol, a synthetic PGE1 analog, in the treatment of duodenal ulcers. A multicenter double-blind study.Dig Dis Sci. 1985 Nov;30(11 Suppl):147S-158S. doi: 10.1007/BF01309402. Dig Dis Sci. 1985. PMID: 3932048 Clinical Trial.
-
Misoprostol in the treatment of duodenal ulcer. A multicenter double-blind placebo-controlled study.Dig Dis Sci. 1985 Nov;30(11 Suppl):159S-163S. doi: 10.1007/BF01309403. Dig Dis Sci. 1985. PMID: 3932049 Clinical Trial.
-
The therapeutic efficacy of misoprostol in peptic ulcer disease.Postgrad Med J. 1988;64 Suppl 1:60-77. Postgrad Med J. 1988. PMID: 3138682 Review.
-
Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.J Physiol Pharmacol. 1994 Dec;45(4 Suppl 1):3-66. J Physiol Pharmacol. 1994. PMID: 7787215 Review.
Cited by
-
Histamine H2-receptor antagonists in peptic ulcer disease. Efficacy in healing peptic ulcers.Drugs. 1992 Nov;44(5):709-19. doi: 10.2165/00003495-199244050-00003. Drugs. 1992. PMID: 1280563 Review.
-
Peptic ulcer characteristics in oral opium and non-opium user patients with upper gastrointestinal bleeding.BMC Gastroenterol. 2024 Jan 22;24(1):42. doi: 10.1186/s12876-024-03137-7. BMC Gastroenterol. 2024. PMID: 38254056 Free PMC article.
-
Profound spatial clustering of simultaneous peptic ulcers.Gut. 1989 Oct;30(10):1329-33. doi: 10.1136/gut.30.10.1329. Gut. 1989. PMID: 2583560 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources